CC
VCYT icon

Corton Capital’s Veracyte VCYT Stock Holding History

Corton Capital’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-11,204
Closed -$381K – 657
2024
Q3 		$381K Buy
+11,204
New +$315K 0.19% 118

Other funds holding VCYT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Corton Capital's VCYT Position: Q4 2024 in Review

Corton Capital sold out of Veracyte (VCYT) in Q4 2024, closing a stake of 11,204 shares — an estimated $381K sold.

Corton Capital first reported a position in VCYT in Q3 2024 and held it in 1 quarter. The position peaked at $381K in Q3 2024. 318 funds tracked by Wall St. Rank hold VCYT as of Q4 2024.

  • Corton Capital reported no remaining Veracyte position as of Q4 2024 after selling out during the quarter.
  • Corton Capital sold 11,204 Veracyte shares in Q4 2024, an estimated $381K.
  • Corton Capital first reported a position in Veracyte in Q3 2024 and held it in 1 quarter.
  • Corton Capital's Veracyte position peaked at $381K in Q3 2024.
  • 318 funds tracked by Wall St. Rank held Veracyte as of Q4 2024.

Based on Corton Capital's 13F filing for Q4 2024, filed 14 Feb 2025.